MedPath

Treatment Management and Factors Affecting Mortality in Retroperitoneal Hemorrhage Due to Cardiac Catheterization; Single Center Experience

Completed
Conditions
Treatment Procedure
Mortality
Interventions
Procedure: Retroperitoneal hematoma due to cardiac catheterization
Registration Number
NCT03006120
Lead Sponsor
Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital
Brief Summary

Bleeding complications after cardiac catheterization have been reviewed previously, but there are very few studies on retroperitoneal hematoma and appropriate treatment of patients is not well defined. For this reason, the investigators aimed to analyze the clinical manifestations of retroperitoneal hematomas in a single center using a case-control study design, to analyze the treatment procedure determinants and consequently to provide an updated and usable treatment algorithm.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
68
Inclusion Criteria
  • Retroperitoneal hematoma following cardiac catheterization
Exclusion Criteria
  • Patients with retroperitoneal hematomas other than cardiac catheterization and patients with missing file records.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Group 2Retroperitoneal hematoma due to cardiac catheterizationAngiografic stenting
Group 1Retroperitoneal hematoma due to cardiac catheterizationConservative management
Group 3Retroperitoneal hematoma due to cardiac catheterizationSurgery
Primary Outcome Measures
NameTimeMethod
Mortality01/01/2010- 31/10/2016
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath